Marsh McLennan's Oliver Wyman to Acquire Healthcare Analytics Business Validate Health
NEW YORK--(BUSINESS WIRE)--Oliver Wyman, a global leader in management consulting and a business of Marsh McLennan (NYSE: MMC), today announced an agreement to acquire Validate Health, a healthcare analytics business that enables healthcare providers and Accountable Care Organizations (ACOs) to better manage costs, risk, and performance. The terms of the transaction, expected to close in summer 2025, were not disclosed.
Validate Health will join Oliver Wyman Actuarial, a specialized business within Oliver Wyman that provides actuarial services to insurers, investors, healthcare providers, corporates and other clients. The acquisition strengthens the business through powerful analytic and technology solutions that help clients grow market size, increase margins, optimize programs, manage risk, and secure investments and funding, while also enhancing patient outcomes.
'Healthcare is a complex and critical industry featuring a unique set of challenges, and it is undergoing a seismic shift,' said David Weinsier, Partner, Global Life and Health Leader for Oliver Wyman Actuarial. 'This acquisition allows us to not only meet that moment but lead it. By combining our deep actuarial and policy expertise with Validate Health's data-driven solutions, we are at the forefront of building an analytics platform that helps clients improve healthcare delivery and drive efficiency.'
Andrew Webster, Validate Health Co-Founder, added, 'This is a milestone moment for us. From the start, our mission has been to make healthcare better through data. Joining forces with Oliver Wyman gives us the reach, actuarial and insurance expertise, and complementary skillsets to supercharge that mission. Our clients – and their patients – stand to gain the most.'
For more information about Oliver Wyman Actuarial services, visit our Actuarial Consulting website.
About Oliver Wyman
Oliver Wyman, a business of Marsh McLennan (NYSE: MMC), is a management consulting firm combining deep industry knowledge with specialized expertise to help clients optimize their business, improve operations and accelerate performance. Marsh McLennan is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit marshmclennan.com, follow us on LinkedIn and X.
About Validate Health
Validate Health provides ongoing actuarial and financial optimization services customized for Accountable Care Organizations (ACOs). It reconstructs the Centers for Medicare and Medicaid Services (CMS) methodology using computer models for MSSP, REACH, Medicare Advantage, and other accountable care programs. Depending on the decision needed, Validate Health simulates the impact of multiple scenarios at different organizational levels, time horizons, and decision frequencies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
IonQ Achieves Quantum Computing First: Simulates Neutrinoless Double-Beta Decay
IonQ Inc. (NYSE:IONQ) is one of the best AI stocks to buy according to hedge funds. On June 25, IonQ made headlines with a significant breakthrough in fundamental physics by achieving the first known simulation of neutrinoless double-beta decay using its quantum computer. This development has profound implications for understanding the universe's matter-antimatter imbalance and suggests that quantum computers could unlock new realms in physics processes previously beyond the reach of classical systems. The simulation was performed on IonQ's Forte Enterprise quantum system, using 32 qubits for the main problem and an additional 4 qubits for error mitigation. A quantum computer on a countertop in an engineering laboratory with a technician at work. This involved 2,356 two-qubit gates and allowed for the real-time observation of a 'lepton-number violation.' The achievement resulted from a year-long co-design effort with researchers from the University of Washington's InQubator for Quantum Simulation (IQuS) and the US Department of Energy's Quantum Science Center. IonQ Inc. (NYSE:IONQ) develops quantum computers and networks in the US. While we acknowledge the potential of IONQ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
1 Profitable Stock with Exciting Potential and 2 to Question
While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity". Profits are valuable, but they're not everything. At StockStory, we help you identify the companies that have real staying power. Keeping that in mind, here is one profitable company that balances growth and profitability and two best left off your watchlist. Trailing 12-Month GAAP Operating Margin: 6.3% Operating through a largely Asian facility footprint, Amkor Technologies (NASDAQ:AMKR) provides outsourced packaging and testing for semiconductors. Why Do We Steer Clear of AMKR? Sales tumbled by 5.1% annually over the last two years, showing market trends are working against its favor during this cycle High input costs result in an inferior gross margin of 14.5% that must be offset through higher volumes Operating margin of 6.9% has deteriorated over the last five years, hampering its adaptability and competitive positioning Amkor is trading at $21.30 per share, or 12.4x forward P/E. Check out our free in-depth research report to learn more about why AMKR doesn't pass our bar. Trailing 12-Month GAAP Operating Margin: 8% Originally a pioneering technology publisher founded in 1927 that became famous for PC Magazine, Ziff Davis (NASDAQ:ZD) operates a portfolio of digital media brands and subscription services across technology, shopping, gaming, healthcare, and cybersecurity markets. Why Do We Pass on ZD? Sales were flat over the last five years, indicating it's failed to expand this cycle Sales over the last five years were less profitable as its earnings per share fell by 1.6% annually while its revenue was flat 17.6 percentage point decline in its free cash flow margin over the last five years reflects the company's increased investments to defend its market position At $30.50 per share, Ziff Davis trades at 4.3x forward P/E. Dive into our free research report to see why there are better opportunities than ZD. Trailing 12-Month GAAP Operating Margin: 36.2% Founded in 1847, Philip Morris International (NYSE:PM) manufactures and sells a wide range of tobacco and nicotine-containing products, including cigarettes, heated tobacco products, and oral nicotine pouches. Why Is PM a Good Business? Unit sales averaged 3% growth over the past two years and imply healthy demand for its products Products command premium prices and result in a best-in-class gross margin of 64.8% Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends, and its rising cash conversion increases its margin of safety Philip Morris's stock price of $180.99 implies a valuation ratio of 24.2x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
1 Momentum Stock to Own for Decades and 2 to Avoid
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance. While momentum can be a leading indicator, it has burned many investors as it doesn't always correlate with long-term success. On that note, here is one stock with lasting competitive advantages and two best left ignored. One-Month Return: +4.2% Founded in 2005 by cybersecurity engineer Nir Zuk, Palo Alto Networks (NASDAQ:PANW) makes hardware and software cybersecurity products that protect companies from cyberattacks, breaches, and malware threats. Why Is PANW Not Exciting? Annual revenue growth of 19.7% over the last three years was below our standards for the software sector Offerings struggled to generate meaningful interest as its average billings growth of 3% over the last year did not impress Palo Alto Networks's stock price of $200.54 implies a valuation ratio of 14x forward price-to-sales. Check out our free in-depth research report to learn more about why PANW doesn't pass our bar. One-Month Return: +34.4% The result of a spinoff from Sanken in Japan, Allegro MicroSystems (NASDAQ:ALGM) is a designer of power management chips and distance sensors used in electric vehicles and data centers. Why Is ALGM Risky? Customers postponed purchases of its products and services this cycle as its revenue declined by 13.7% annually over the last two years Falling earnings per share over the last four years has some investors worried as stock prices ultimately follow EPS over the long term 10.5 percentage point decline in its free cash flow margin over the last five years reflects the company's increased investments to defend its market position Allegro MicroSystems is trading at $34.08 per share, or 67.7x forward P/E. Dive into our free research report to see why there are better opportunities than ALGM. One-Month Return: +8.5% Notoriously funded with $7.7 billion from the Softbank Vision Fund, Uber (NYSE:UBER) operates a platform of on-demand services such as ride-hailing, food delivery, and freight. Why Will UBER Beat the Market? Monthly Active Platform Consumers are rising, meaning the company can increase revenue without incurring additional customer acquisition costs if it can cross-sell additional products and features Incremental sales over the last three years have been highly profitable as its earnings per share increased by 183% annually, topping its revenue gains Free cash flow margin grew by 17.7 percentage points over the last few years, giving the company more chips to play with At $91.30 per share, Uber trades at 21.6x forward EV/EBITDA. Is now the time to initiate a position? Find out in our full research report, it's free. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Sign in to access your portfolio
